When price cut playing cards may also help relieve the load of large drug expenses within the short-term, they don't handle the systemic issues driving up prescription rates while in the U.S. Broader policy changes could deal with the basis will cause of rising drug rates, for example insufficient transparency in pricing and also the part of interm